Routine antinuclear antibody testing as an independent prognostic biomarker for end-stage renal disease in ANCA-associated vasculitis: a longitudinal cohort study
Routine antinuclear antibody testing as an independent prognostic biomarker for end-stage renal disease in ANCA-associated vasculitis: a longitudinal cohort study. // Clinica Chimica Acta. – URL: https://www.sciencedirect.com/science/article/pii/S0009898126021224?dgcid=rss_sd_all
Routine antinuclear antibody testing as an independent prognostic biomarker for end-stage renal disease in ANCA-associated vasculitis: a longitudinal cohort study. Clinica Chimica Acta. https://www.sciencedirect.com/science/article/pii/S0009898126021224?dgcid=rss_sd_all
“Routine antinuclear antibody testing as an independent prognostic biomarker for end-stage renal disease in ANCA-associated vasculitis: a longitudinal cohort study.” Clinica Chimica Acta.
@article{article40426,
title = {Routine antinuclear antibody testing as an independent prognostic biomarker for end-stage renal disease in ANCA-associated vasculitis: a longitudinal cohort study},
journal = {Clinica Chimica Acta},
url = {https://www.sciencedirect.com/science/article/pii/S0009898126021224?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...